To update an existing systematic review series 1,2 of randomized controlled trials (RCT) that include a 44 dietary intervention for the management of overweight or obesity in children or adolescents. 
Background

54
Over the past four decades overweight and obesity prevalence has increased globally in children. 3 Once 55 considered a problem only in high-income countries, prevalence of overweight and obesity is increasing 56 in low-and middle-income countries, particularly in urban settings. The magnitude of these changes 57 are such that in 1980, 8% and 16% of children from developing and developed countries, respectively, 58 were overweight (including obese), and by 2013 these rates had increased to around 13% and 23-24%, 59
respectively. 3 At the upper-end of the weight spectrum, recent estimates suggest that worldwide in 60 2015, 107.7 million (~5%) children under 20 years of age were obese 4 , and in 2016, 41 million (~6%) 61 children under five years of age were classified as having moderate-severe overweight. 5 62
Overweight, and especially obesity, in childhood is a significant public health issue due to its impact on 63 health and quality of life in childhood 6 and its propensity to persist into adulthood. 7 Aside from the impact 64 of overweight and obesity on individuals, its global economic impact is estimated to be in the order of 65 trillions of dollars annually. 8 The health consequences of childhood overweight and obesity that may 66 present in childhood include: delayed motor development, asthma, obstructive sleep apnoea, 67 dysglycemia and type 2 diabetes, elevated blood pressure, dyslipidemia, chronic inflammation, 68 muscular skeletal problems, accelerated maturation, psychological difficulties and disorders, non-69 alcoholic fatty liver disease, gastroenterological problems and reproductive problems. 6 In adults, 70 overweight and obesity is associated with increased risk of all-cause mortality, 9,10 and the incidence ofchild and adolescent overweight and obesity, effective strategies are required for populations already 75 affected. The cornerstone of managing child and adolescent overweight and obesity is family-centered, 76 multicomponent lifestyle intervention based on dietary, physical activity and behavioral modification. 12,13 77
Lifestyle interventions can reduce body mass index (BMI), and improve other cardiometabolic outcomes 78 including blood lipids, fasting insulin and glucose, and blood pressure in children and adults. 14-19 79
In 2007 our original systematic review on best practice dietetic management of overweight and obese 80 children and adolescents was published, 1 and the first update was published in 2013. 2 Data gathered 81 in those reviews also formed the basis of several secondary reviews on related topics. [14] [15] [20] [21] [22] This 82 series of reviews has been widely cited in over 125 peer-reviewed publications. Given the prevalence 83 of overweight and obesity in childhood remains at a historical high, and the seriousness of its 84 consequences, a second update of our review on best practice dietetic management of overweight and 85 obese children and adolescents is warranted. In parallel, a series of Cochrane reviews on interventions 86 for the treatment of child and adolescent overweight and obesity management were published between 87
2003 and 2017, those reviews included but were not restricted to interventions that featured a dietary 88 component. [23] [24] [25] [26] [27] [28] [29] [30] There is some overlap between our series of reviews and the Cochrane review series 89 with regards to the reporting of adiposity outcomes. However, the novel aspect of our primary 90 systematic review and its update 1,2 is that we examine in detail the dietary outcomes of the included 91 dietary interventions, and also the characteristics of these interventions which are associated with 92 improvement in adiposity and dietary outcomes. 93
This second update of our review on best practice dietetic management of overweight and obese 94 children and adolescents will provide key information to inform clinical practice guideline and policy 95 development. It will also identify gaps in the evidence base requiring further research and potential 96 areas where innovations in dietary management are needed to improve adiposity and dietary outcomes. 97
This protocol is based on that used for the first update of this review. 31 This review will include interventions targeting children or adolescents who at baseline are less than 20 110 years of age, and who are defined as overweight or obese. 111
Participants will be free living outpatients or inpatients in obesity clinical units or attending community 112 programs, camps, school or one-off programs. Interventions directed exclusively at parents of eligible 113 participants will also be reviewed. Studies will be excluded if they focus on children or adolescents with 114 obesity attributable to a secondary or syndromal cause with the exception of Type 2 Diabetes Mellitus 115 or its precursor states. 116
Types of intervention 117
Nutrition or dietary interventions of interest will be those used for the treatment of elevated body weight. 118
Interventions will include but not be limited to those provided by: 119  a dietitian solely; 120  a dietitian and other health professionals; or 121  other professionals including obesity clinics, practice nurses, GPs, commercial programs, train-122 the-trainer, community groups, gyms, schools or via the internet, telephone or mail. 123
The intervention focus may be described as: lifestyle modification, including modification of dietary 124 intake alone (inclusive of meal replacements and dietary supplements), or combined with cognitive 125 behavioral therapy and/or physical activity and/or sedentary behavior modification and/or 126 pharmacotherapy and/or a surgical intervention. 127
Childhood obesity prevention RCTs will be excluded. For the purpose of this review obesity prevention 128 interventions are defined as the implementation of strategies to limit excess weight gain in samples that 129 include healthy weight children or adolescents. 130
Types of comparator groups 131
Acceptable control groups will include no treatment/wait-list control, usual care, a lower dose or intensity 132 of treatment (e.g. minimal advice, written education materials) or an alternative treatment. 133
Types of outcomes 134
Measures of outcome will include but not be limited to changes in: 135  body composition, including % body fat or % lean body mass; or 140  any measure related to diet, nutrition or eating. For example dietary intake, dietary behaviors, 141 nutrition knowledge and attitudes, social cognitive theory constructs that relate to eating 142 behaviors (e.g. eating intentions, self-efficacy in making food choices). 143
Types of studies 144
Given the large volume of RCTs identified by our previous reviews, 1 All citations identified through the search strategy will be imported into Covidence. 35 Initially two 158 reviewers will use Covidence to independently screen studies for eligibility against the inclusion criteria, 159 based on information contained in the title and abstract. Full texts of all potentially relevant articles will 160 then be retrieved and uploaded to Covidence. Two reviewers will examine the full text articles through 161
Covidence and will independently designate if the study meets the inclusion criteria. Conflicts in 162 eligibility decisions will be resolved by a third reviewer. 163
164
Assessment of methodological quality
165
All studies that meet the inclusion criteria for this review will be independently assessed for 166 methodological quality by two reviewers, using the JBI Critical Appraisal Checklist for RCTs. 36 We will 167 modify item 11, so that item 11a will be "Were adiposity-related outcomes measured in a reliable way?" 168 and item 11b will be "Were dietary outcomes measured in a reliable way?". Responses will be recordedthe quality of the included studies with a clear indication of the risks of bias present. 172
173
Data extraction
is disagreement between reviewers regarding the extracted data, a third reviewer will be consulted. If 180 additional information about an included study is required then authors of the study will be contacted. 181
182
Data synthesis
183
Results of comparable RCTs will be pooled in a meta-analysis to determine the effectiveness of the 184 intervention. Comparability of the studies will be defined by the population, interventions, comparator 185 groups and outcome measures. Review Manager will be used to perform meta-analyes. 37 Chi square 186 and visual interpretation of graphs will be used to assess heterogeniety. Significant heterogeneity will 187 be defined when the p value is less than 0.05. Odds ratio will be used to summarize effect for 188 dichotomous data, while the weighted mean difference or standardized mean difference will be used 189 for continuous data. Where statistical pooling is not possible the findings will be presented in narrative 190 form including tables and figures to aid in data presentation where appropriate. The Preferred Reporting 191
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement will be used in preparation of 192 the final report. 38 
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